Clinical trial · Observational
Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Shorten the time spent in the hospital (hospitalization duration) by optimizing the pre, per and postoperative care is of major medical and economic importance. Minimally invasive surgery allows a faster recovery than open surgery. However, we need to ensure an early and secure return to normality in order to discharge patients safely from the hospital. Clinical and biological parameters need to be controlled post-surgery. This work is going to evaluate the efficacity of a fast - recovery program with incoming patients receiving minimally invasive surgery (laparoscopic or robotic) of partial and total nephrectomy. The implementation of a medical and surgical fast-recovery program could * Lower the average duration of stay in hospital (at least by 1 day) with no increase of morbidity * Insure the absence of complications after 6 months home
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| enhanced recovery after surgery program | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients
- description
- undergoing a minimally invasive nephrectomy, eligible to an Enhanced Recovery After Surgery Program.
- interventionNames
- Procedure: enhanced recovery after surgery program
Primary outcomes (1)
- measure
- Length of hospital stay
- timeFrame
- at 1 month
Secondary outcomes (5)
- measure
- Hospital readmission rate at 1 month post surgery
- timeFrame
- at 1 month
- measure
- Postoperative antalgic consumption in Enhanced recovery after surgery patients
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patient score from the American Society of Anesthesiologist (ASA) I, II or III stable * Patients undergoing minimally invasive surgery (laparoscopic or robotic) partial or total unilateral nephrectomies for tumoral \< pT2 stage (7 cm) with no tumor spread of the retro-peritoneal tissue, vascular or urinary tract. * Surgery must be performed by a laparoscopic and robotic-assisted surgeon, operator must be trained using these techniques Exclusion Criteria: * Patient score from the American Society of Anesthesiologist (ASA) III unstable, IV and V * Patients with renal insufficiency defined by clearance \< 60 ml/min/1,73m2 (CKD-EPI) * Patients with high embolic risk under long-term anti-coagulation medication * Patients with congenital hemostatic deficit or antiplatelet treatment * Patients with long term corticosteroids treatments * History of kidney surgery or congenital unique kidney * History of multiple abdominal surgery creating a hostile surgical environment * intestinal chronic disease or chronic pain syndrome * Psychiatric disorder, cognitive impairment reducing the ability to understand the discharge instructions * Pregnant or breast-feeding women * Patients with no social security covers
References
Publications (0)
Data not yet available